Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Precision Medicine in Oncology^®

Breast Cancer

Gastrointestinal Cancer

Precision Medicine in Oncology^®

Precision Medicine Propels Research Efforts in Breast Cancer

Mark E. Robson, MD, provides a snapshot of the precision focus in breast cancer, as well as the emergence of biosimilars in the field.
Read More >>

Genomic Era Trials Drive Discovery

Vorasidenib, Ivosidenib Show Encouraging Activity in IDH1-Mutant Low-Grade Glioma

Prognostic and Predictive Assays Guide Therapy Decisions in Breast Cancer

BRCA Rules Leave Patients Behind

IDO Inhibitor Development Shows Fresh Signs of Life Across Tumor Types

View More Stories >>

View Conference Coverage

2019 San Antonio Breast Cancer Symposium

2019 ASH Annual Meeting

2019 International Congress of the Society for Melanoma Research

2019 State of the Science Summit on Genitourinary Cancers in Nashville

2019 State of the Science Summit on Hematologic Malignancies in Chicago

Dr. Papadimitrakopoulou on Implications of the NILE Trial in NSCLC

Dr. Papadimitrakopoulou on Benefits of Liquid Biopsy Versus Standard Tissue in Lung Cancer

Dr. Papadimitrakopoulou on Distinguishing Features of the Guardant360 Assay in Lung Cancer

Dr. Papadimitrakopoulou on the Utility of Liquid Biopsies in NSCLC

Dr. Chavez Mac Gregor on Chemotherapy in Node-Positive HR+/HER2- Breast Cancer

Dr. Strickler on Genomic Variants Detected by Liquid Biopsies in GI Cancers

OncLive houses thousands of videos that provide updates and information.
See more Videos

Hepatocellular Carcinoma: Antiangiogenic Therapy Options

Targeted Therapy for KRAS-Mutant NSCLC

Treatment of NSCLC With RET Fusions

Treatment of Germline BRCA with PARP and Checkpoint

OncLive houses thousands of videos that provide updates and information.
See more Videos

TRK Inhibition: Future Challenges and Evolutions

Use of TRK Inhibition in Specific Tumor Types

The Importance and Evolution of NGS Testing

Envisioning Use of TRK Inhibitors in Clinical Practice

TRK Inhibition in CNS Tumors or Metastases

Considering Available Data for Entrectinib

TRK Inhibition: Personal Experience With Larotrectinib

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Program

Treatment of Advanced Head & Neck Squamous Cell Carcinoma

Ezra Cohen, MD; Robert Ferris, MD, PhD, FACS; and Jared Weiss, MD, provide a comprehensive overview of diagnosis and treatment of advanced head and neck squamous cell carcinoma (HNSCC), including multidisciplinary care and emerging evidence surrounding novel therapies. Treatment approaches to HPV-positive and HPV-negative tumors are explored.

Melanoma Updates

Pembrolizumab/Ipilimumab Shows Promising Efficacy
James Allison Predicts ‘Cures’ With Checkpoint Inhibitor Combinations
Nivolumab Survival Benefit Sustained in Updated Data
Novel T-VEC Combos Mark Next Phase of Oncolytic Immunotherapy Era
Novel Treatments, Targets Next Step in Immuno-Oncology Revolution

Download the meeting reporter >>>

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

OncLive News Network On Location: ASH 2019 Day 3